Group One Trading, L.P. Sio Gene Therapies Inc. Transaction History

Group One Trading, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$0.28 - $0.41 $3 - $5	-14 Reduced 1.53%	902 $0
Q2 2022 Aug 11, 2022	SELL	$0.25 - $0.73 $512 - $1,495	-2,048 Reduced 69.1%	916 $0
Q1 2022 May 12, 2022	SELL	$0.55 - $1.47 $990 - $2,646	-1,800 Reduced 37.78%	2,964 $2,000
Q4 2021 Feb 11, 2022	SELL	$1.29 - $2.36 $65,760 - $120,305	-50,977 Reduced 91.45%	4,764 $6,000
Q3 2021 Nov 12, 2021	SELL	$1.81 - $2.7 $54,482 - $81,272	-30,101 Reduced 35.07%	55,741 $121,000
Q2 2021 Aug 10, 2021	SELL	$2.07 - $2.89 $60,253 - $84,122	-29,108 Reduced 25.32%	85,842 $234,000
Q1 2021 May 12, 2021	BUY	$2.34 - $3.44 $268,983 - $395,428	114,950 New	114,950 $300,000

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.